Editor's Note: This is a preview of Clinical Researcher—December 2017 (Volume 31, Issue 6). The full contents will be posted online December 12. Paula Smailes, MSN, RN, CCRC, CCRP [DOI: 10.14524/CR-17-4044] Our clinical research careers are not stagnant. They change, but what makes them change? Do we take steps as individuals to do it ourselves, […]
“What’s clinically meaningful to patients?” Jonathan Goldsmith, MD, associate director of the Rare Disease Program of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) asked the attendees of the FDA/CMS Summit in Washington, D.C. this week. When developing a clinical trial for a rare disease, Goldsmith encouraged […]
Fueled by new technologies and a growing commitment to patient-centric trials, patient-reported outcomes (PROs) are becoming increasingly important in the conduct of successful clinical trials. That’s the ground-level assessment of experts at the FDA/CMS Summit held this week in Washington, D.C. “We’ve been talking [about PRO] for 20 years, but I think technology is pushing […]
Study site leaders who are new to the business of conducting clinical trials are sometimes “naïve” and hesitant to ask probing questions as they work with sponsors to define study parameters at the outset, says Marcus Stone, PhD, CEO of the Spine Institute of Louisiana Foundation. “First, there is some fear of losing the business,” […]
Sites looking to improve patient recruitment and retention might want to consider offering some home cooking, says Nicki Norris, MBA, the CEO of Symphony Clinical Research. Too often, recruiters and other site personnel forget patients have busy lives. Participating in a trial, as important as it may be, is only one of the items on […]
